Back to video list Back to Home Eptinezumab – an efficacious, fast and sustained anti-CGRP monoclonal antibody therapy for preventive migraine treatment You may also like Alzheimer's Disease Article Could targeting the brain’s clearance systems be beneficial in Alzheimer’s Disease? Parkinson's Disease Article Ethics in movement disorders – what the clinician needs to know Bipolar Schizophrenia Article Brain connectivity in early psychosis and during effective antipsychotic therapy Schizophrenia Article Steps towards long-term maintenance treatment for psychiatric disorders